Cetera Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Cetera Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-526	Closed	-$22K	–	1296
2019 Q1	$22K	Buy	+526	New	+$21.4K	﹤0.01%	1067
2016 Q4	–	Sell	-10,686	Closed	-$471K	–	818
2016 Q3	$471K	Buy	10,686 +232	+2%	+$10.5K	0.04%	425
2016 Q2	$438K	Sell	10,454 -337	-3%	-$14.3K	0.03%	450
2016 Q1	$434K	Buy	10,791 +2,054	+24%	+$87K	0.04%	431
2015 Q4	$443K	Buy	8,737 +115	+1%	+$5.86K	0.04%	429
2015 Q3	$403K	Buy	8,622 +934	+12%	+$56.3K	0.04%	417
2015 Q2	$477K	Buy	7,688 +42	+0.5%	+$2.62K	0.04%	394
2015 Q1	$474K	Buy	7,646 +1,344	+21%	+$79.7K	0.04%	397
2014 Q4	$339K	Buy	+6,302	New	+$344K	0.03%	450

Other funds holding XPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Cetera Advisors's XPH Position: Q2 2019 in Review

Cetera Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2019, closing a stake of 526 shares — an estimated $22K sold.

Cetera Advisors first reported a position in XPH in Q4 2014 and held it in 9 quarters. The position peaked at $477K in Q2 2015. 61 funds tracked by Wall St. Rank hold XPH as of Q2 2019.

Cetera Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
Cetera Advisors sold 526 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2019, an estimated $22K.
Cetera Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2014 and held it in 9 quarters.
Cetera Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $477K in Q2 2015.
61 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2019.

Based on Cetera Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.